MRNA Moderna, Inc. Stock Quote

MRNA [NASD]

Index	-	P/E	-	EPS (ttm)	-1.94	Insider Own	2.50%	Shs Outstand	396.81M	Perf Week	6.31%
Market Cap	53.58B	Forward P/E	9.48	EPS next Y	14.87	Insider Trans	-55.69%	Shs Float	356.19M	Perf Month	8.61%
Income	-747.10M	PEG	-	EPS next Q	3.21	Inst Own	50.40%	Short Float	4.20%	Perf Quarter	22.44%
Sales	803.40M	P/S	66.69	EPS this Y	-26.10%	Inst Trans	-2.18%	Short Ratio	1.34	Perf Half Y	94.72%
Book/sh	6.45	P/B	21.85	EPS next Y	-31.96%	ROA	-17.00%	Target Price	174.25	Perf Year	334.67%
Cash/sh	12.12	P/C	11.63	EPS next 5Y	16.80%	ROE	-30.20%	52W Range	31.71 - 189.26	Perf YTD	34.89%
Dividend	-	P/FCF	27.34	EPS past 5Y	-	ROI	-28.40%	52W High	-25.16%	Beta	-
Dividend %	-	Quick Ratio	1.40	Sales past 5Y	-	Gross Margin	99.00%	52W Low	346.68%	ATR	8.67
Employees	1300	Current Ratio	1.40	Sales Q/Q	3960.80%	Oper. Margin	-95.00%	RSI (14)	53.14	Volatility	5.48% 6.01%
Optionable	Yes	Debt/Eq	0.05	EPS Q/Q	-86.50%	Profit Margin	-93.00%	Rel Volume	0.75	Prev Close	140.92
Shortable	Yes	LT Debt/Eq	0.04	Earnings	Feb 25 BMO	Payout	-	Avg Volume	11.18M	Price	141.64
Recom	2.60	SMA20	3.96%	SMA50	-5.35%	SMA200	35.59%	Volume	581,139	Change	0.51%

Feb-01-21

Downgrade

BofA Securities

Neutral → Underperform

Dec-16-20

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$150

Dec-16-20

Downgrade

Jefferies

Buy → Hold

$90 → $150

Dec-09-20

Downgrade

Needham

Buy → Hold

Nov-23-20

Initiated

Wells Fargo

Equal Weight

$92

Nov-17-20

Downgrade

BMO Capital Markets

Outperform → Market Perform

$109

Sep-08-20

Downgrade

SVB Leerink

Mkt Perform → Underperform

$58 → $41

Jul-23-20

Initiated

SVB Leerink

Mkt Perform

Jul-20-20

Downgrade

JP Morgan

Overweight → Neutral

$89

Jul-13-20

Initiated

Jefferies

Buy

$90

Jun-30-20

Initiated

Argus

Buy

$80

Jun-08-20

Initiated

Barclays

Overweight

$68

Apr-30-20

Initiated

BMO Capital Markets

Outperform

$83

Mar-05-20

Downgrade

BofA/Merrill

Buy → Neutral

$32

Dec-03-19

Resumed

BofA/Merrill

Buy

Oct-25-19

Initiated

ROTH Capital

Buy

$24

Apr-05-19

Initiated

Chardan Capital Markets

Buy

$40

Apr-12-21 04:30AM	UPDATE 1-Spain's Rovi to make ingredients for Moderna's COVID-19 vaccine Reuters
03:41AM	Rovi to make active agents for Moderna COVID-19 vaccine Reuters
Apr-10-21 10:29AM	Moderna Co-Founder Noubar Afeyan Sells Large Blocks of Stock Barrons.com
06:30AM	3 Stocks That Could Suffer if Biden Gives In to This Pressure Motley Fool
Apr-09-21 05:23PM	"A big hit to the vaccine campaign": Doctor on Johnson & Johnson's vaccine delivery plunge Yahoo Finance Video +5.26%
04:23PM	UPDATE 1-Italy not in talks for more COVID-19 vaccines with Moderna -govt official Reuters
04:20PM	Bristol Myers' (BMY) Opdivo Combo Positive in ESCC Study Zacks
01:39PM	Pfizers vaccine EUA expansion request is extremely welcomed: Doctor Yahoo Finance Video
12:12PM	Why Moderna Stock Is Jumping Today Motley Fool
11:46AM	The Michigan spike is something we should be nervous about: Doctor Yahoo Finance Video
11:30AM	COVID SCIENCE-Moderna vaccine antibodies last at least 6 months; lung transplant can save some COVID-19 survivors Reuters
09:55AM	Europe probes possible blood clot link with Johnson & Johnson COVID vaccine Yahoo Finance UK
09:55AM	Lilly's (LLY) JAK Inhibitor Olumiant Fails COVID-19 Study Zacks
09:11AM	J&J Vaccine Dose Allocations Will Drop Next Week. It Wont Have an Immediate Effect on Availability. Barrons.com
08:00AM	Moderna to Present at the 20th Annual Needham Virtual Healthcare Conference Business Wire
06:00AM	This Is Why Moderna Is a Great Stock to Buy Right Now Motley Fool
05:52AM	3 Robinhood Stocks That Are Ridiculously Cheap Motley Fool
Apr-08-21 05:00PM	Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus Zacks
04:53PM	Fauci: new Covid-19 cases are at a disturbing level, U.S. is primed for a surge Yahoo Finance Video
03:23PM	Study shows wearables could detect COVID-19 earlier Yahoo Finance Video
01:23PM	COVID-19 vaccinations are extraordinarily safe: Doctor Yahoo Finance Video
07:30AM	Inovio Is Still Working On A Midstage Covid Vaccine Test Is It A Buy? Investor's Business Daily
04:50AM	Oxford scientists behind COVID-19 vaccine set for multimillion pound payday Yahoo Finance UK
Apr-07-21 07:27PM	Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months in the New England Journal of Medicine Business Wire
02:23PM	Is It Time to Buy the Nasdaq's Biggest Dippers? Motley Fool
02:05PM	We will fight in protecting the right to vote: Michigan Lt. Governor Yahoo Finance Video
02:03PM	Coronavirus: 'We are seeing so many younger patients' Yahoo Finance
01:26PM	COVID-19 mitigation is the most effective weapon to avoid fourth wave: Doctor Yahoo Finance Video
12:28PM	NIH Starts Study On Allergic Reactions Risk To Pfizer/BioNTech, Moderna COVID-19 Vaccines Benzinga
12:20PM	Earnings Estimates Rising for Moderna (MRNA): Will It Gain? Zacks
11:18AM	CDC says now-dominant variant poses risk even with nearly 20% of U.S. fully vaccinated MarketWatch
11:01AM	White House wont support vaccine passports: Psaki Yahoo Finance Video
10:11AM	UPDATE 1-U.S. begins study on allergic reaction risk in Moderna, Pfizer vaccines Reuters
09:36AM	U.K. to Brief on AstraZeneca Vaccine as Safety Concerns Grow Bloomberg
09:36AM	Company News for Apr 7, 2021 Zacks
08:00AM	Catalent (CTLT) Expands Deal With Moderna for COVID-19 Vaccine Zacks
07:42AM	5 Stocks With High Earnings Yield for Superior Returns Zacks
07:00AM	Moderna Stock Has Come Off Its Recent Highs Is It A Buy Right Now? Investor's Business Daily
07:00AM	This Vaccine Maker May Be Next to Go After the Kids' Market Motley Fool
06:33AM	U.K. rollout of Moderna COVID-19 vaccine begins in Wales MarketWatch
06:30AM	UPDATE 1-Moderna says Europe-bound COVID-19 vaccine deliveries are on track Reuters
06:01AM	3 Top Biotech Stocks to Buy in April Motley Fool
06:00AM	3 Hot Stocks That Could Double Your Stimulus Check Motley Fool
05:29AM	Moderna has not told Germany of changes to vaccine delivery plans- ministry Reuters
05:27AM	AstraZeneca stock under pressure ahead of European Medicines Agency briefing on COVID vaccine Yahoo Finance UK
05:18AM	Moderna says April COVID-19 vaccine deliveries are on track Reuters
01:56AM	UPDATE 4-UK launches rollout of Moderna COVID vaccine as daily shots slow Reuters
01:37AM	UK begins rollout of Moderna Covid vaccine in Wales Reuters
Apr-06-21 02:43PM	Biotech company Kaleido develops oral therapy for COVID-19 Yahoo Finance Video
01:29PM	Theres increasing confidence vaccine supply can meet demand: Doctor Yahoo Finance Video
01:14PM	Research letter indicates that Moderna's COVID-19 vaccine has efficacy past 6 months MarketWatch
12:00PM	Moderna Rises as Testing Shows COVID Antibodies Last at Least 6 Months TheStreet.com
11:09AM	The next few weeks 'are going to be critical,' Fauci warns Yahoo Finance
10:41AM	Biden advances timeline for COVID vaccine eligibility as experts warn Americans, the war is not yet won MarketWatch
09:53AM	Cidara (CDTX) Inks Agreement With J&J for Influenza Therapies Zacks
09:00AM	Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Modernas COVID-19 Vaccine and Clinical Portfolio Business Wire
08:00AM	Yahoo Finance Presents: Director of the NIAID Dr. Anthony Fauci Yahoo Finance Video
07:47AM	3 Top Growth Stocks to Buy That Were Down More Than 15% in March Motley Fool
06:57AM	Pfizer's CEO Makes a Claim That Might Shock Anyone Holding Moderna or BioNTech Stock Motley Fool
06:46AM	Catalent To Boost Output Of Finished Vials For Moderna's COVID-19 Shot: WSJ Benzinga
06:26AM	UPDATE 2-Catalent signs deal with Moderna to speed up U.S. vaccine output Reuters
06:24AM	Contract drug maker Catalent to double production of Moderna COVID vaccine: WSJ MarketWatch
05:23AM	AstraZeneca under pressure as UK considers under-30s ban Yahoo Finance UK
02:45AM	Britain to deploy Moderna COVID-19 shot from third week of April - minister Reuters
Apr-05-21 07:24PM	Moderna vs. the Lobbyists: Who Has the Upper Hand? TipRanks
04:14PM	The IBD/TIPP Poll Gives These 3 Covid Vaccine Stocks Reason To Be Bullish Investor's Business Daily
02:06PM	Travel boom poses threat to COVID-19 recovery: Doctor Yahoo Finance Video
01:23PM	JPMorgan Investor Survey Cites Moderna, Novavax as Ripe to Fall Bloomberg
11:40AM	Moderna, Novavax Make JPMorgan Short Pick List TheStreet.com
07:45AM	Is J&J Stock A Buy Now That The FDA Has Authorized Its Covid Vaccine? Investor's Business Daily
07:18AM	FDA Authorizes Two Vial Presentations For Moderna's COVID-19 Vaccine Benzinga
05:37AM	Vaccine Stocks Checkup: Johnson & Johnson, Pfizer Update TheStreet.com
02:05AM	Covid-19 Vaccine Update And Outlook Amid New Variants, Hiccups For Some Vaccine Developers Investor's Business Daily Video
Apr-04-21 08:00AM	Here Are 3 Tips for COVID Vaccine Investing Right Now Motley Fool
Apr-03-21 10:48AM	AstraZeneca woes continue as the Netherlands halts vaccine Yahoo Finance UK
08:00AM	Here's the Next Catalyst for Moderna Shares Motley Fool
06:00AM	This Could Be a New Billion-Dollar Market for Moderna Motley Fool
06:00AM	Should Investors Worry About This Announcement From Moderna? Motley Fool
Apr-02-21 03:02PM	Teslas Quarterly Deliveries Beat Estimates. How to Play the Good News. Barrons.com
09:44AM	FDA Eases Storage Restrictions for Modernas Covid-19 Vaccine Barrons.com
09:32AM	Global tally of COVID cases edges closer to 130 million, as Fauci says U.S. may not need AstraZeneca vaccine MarketWatch
07:03AM	Is Pfizer Giving Its Partner BioNTech the Shaft by Developing mRNA Vaccines on Its Own? Motley Fool
06:21AM	Coronavirus tally: Global cases of COVID-19 close to 130 million and U.S. death toll tops 553,000 MarketWatch
Apr-01-21 11:25PM	UPDATE 1-Moderna gets nod to speed up virus vaccine output with bigger vials Reuters
11:19PM	FDA approves new Moderna vials to provide extra COVID-19 vaccine doses MarketWatch
10:30PM	Moderna gets nod to fill up to 15 doses per vial of its COVID-19 vaccine Reuters
10:23PM	Moderna gets nod to fill up to 15 doses per vial of its COVID-19 vaccine Reuters
09:45PM	Moderna Provides Storage Update & Announces the U.S. FDA Authorizes Up To 15-Doses Per Vial of its COVID-19 Vaccine Business Wire
05:45PM	Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know Zacks
02:46PM	Quidel issued first emergency use authorization by FDA for a COVID-19 antigen test Yahoo Finance Video
02:07PM	How Bidens momentous rescue plan helps older Americans: NCOA President Yahoo Finance Video
01:46PM	Layers of mitigation against the virus remains critical: Doctor Yahoo Finance Video
01:24PM	Pfizer Trials Show Vaccine Is Effective for At Least Six Months Barrons.com
12:01PM	Anytime theres a bad headline about these vaccines, its going to add to vaccine hesitancy: Dr. Amesh Adalja Yahoo Finance Video
11:07AM	Ximedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines PR Newswire
10:00AM	Did Pfizer Just Leap Ahead of Moderna in This Key Market? Motley Fool
09:34AM	Oxford startup raises £685,000 to develop 'variant-proof' vaccines Yahoo Finance UK
08:13AM	The Zacks Analyst Blog Highlights: Comcast, Netflix, PepsiCo, General Electric and Moderna Zacks
07:07AM	Pfizer/BioNTech vaccine effective after 6 months; Moderna starts variant trial Yahoo Finance
06:50AM	Pfizer (PFE)/BioNTech COVID-19 Vaccine 100% Effective in Teens Zacks

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., and Recipharm for fill-finish manufacturing of its COVID-19 vaccine candidate. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HENDERSON LORI M.	General Counsel and Secretary	Apr 08	Option Exercise	20.93	6,600	138,138	7,501	Apr 09 04:27 PM
Bancel Stephane	Chief Executive Officer	Apr 08	Sale	132.85	10,000	1,328,500	7,464,880	Apr 09 04:15 PM
HENDERSON LORI M.	General Counsel and Secretary	Apr 08	Sale	132.85	6,600	876,810	901	Apr 09 04:27 PM
Andres Juan	See remarks	Apr 07	Option Exercise	12.21	5,000	61,050	5,000	Apr 08 04:11 PM
Andres Juan	See remarks	Apr 07	Sale	131.63	5,000	658,150	0	Apr 08 04:11 PM
Bancel Stephane	Chief Executive Officer	Apr 07	Sale	131.63	9,000	1,184,670	6,369,868	Apr 09 04:15 PM
HENDERSON LORI M.	General Counsel and Secretary	Apr 06	Option Exercise	20.93	6,600	138,138	7,501	Apr 08 04:09 PM
HENDERSON LORI M.	General Counsel and Secretary	Apr 06	Sale	130.01	6,600	858,066	901	Apr 08 04:09 PM
Hoge Stephen	President	Apr 05	Option Exercise	0.99	20,000	19,800	1,629,597	Apr 06 04:07 PM
Andres Juan	See remarks	Apr 05	Option Exercise	12.21	5,000	61,050	5,000	Apr 06 04:11 PM
Zaks Tal Zvi	Chief Medical Officer	Apr 05	Option Exercise	12.21	5,000	61,050	5,000	Apr 06 04:13 PM
Bancel Stephane	Chief Executive Officer	Apr 05	Sale	129.77	11,046	1,433,417	88,384	Apr 06 04:05 PM
Hoge Stephen	President	Apr 05	Sale	132.63	20,000	2,652,600	1,609,597	Apr 06 04:07 PM
Andres Juan	See remarks	Apr 05	Sale	132.63	5,000	663,150	0	Apr 06 04:11 PM
Zaks Tal Zvi	Chief Medical Officer	Apr 05	Sale	129.71	5,000	648,530	0	Apr 06 04:13 PM
HENDERSON LORI M.	General Counsel and Secretary	Apr 01	Option Exercise	20.93	6,600	138,138	7,501	Apr 02 10:30 AM
HENDERSON LORI M.	General Counsel and Secretary	Apr 01	Sale	132.51	6,600	874,566	901	Apr 02 10:30 AM
Bancel Stephane	Chief Executive Officer	Apr 01	Sale	132.51	10,000	1,325,100	7,474,880	Apr 02 10:34 AM
Bancel Stephane	Chief Executive Officer	Mar 31	Sale	121.10	9,000	1,089,900	6,380,868	Apr 02 10:34 AM
AFEYAN NOUBAR	Director	Mar 31	Sale	121.07	4,888	591,810	9,116,657	Mar 31 08:00 PM
AFEYAN NOUBAR	Director	Mar 30	Sale	118.97	2,112,795	251,366,680	9,121,545	Mar 31 08:00 PM
Andres Juan	See remarks	Mar 29	Option Exercise	12.21	5,000	61,050	5,000	Mar 30 04:51 PM
AFEYAN NOUBAR	Director	Mar 29	Sale	124.60	1,635,122	203,734,064	11,234,340	Mar 31 08:00 PM
Andres Juan	See remarks	Mar 29	Sale	130.05	5,000	650,250	0	Mar 30 04:51 PM
Bancel Stephane	Chief Executive Officer	Mar 26	Sale	132.76	11,046	1,466,464	99,430	Mar 30 04:51 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 25	Option Exercise	20.93	6,600	138,138	7,501	Mar 26 04:33 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 25	Sale	126.88	6,600	837,408	901	Mar 26 04:33 PM
Bancel Stephane	Chief Executive Officer	Mar 25	Sale	126.88	10,000	1,268,800	7,484,880	Mar 26 04:34 PM
Hoge Stephen	President	Mar 24	Option Exercise	10.90	5,000	54,500	1,614,597	Mar 25 04:13 PM
Andres Juan	See remarks	Mar 24	Option Exercise	12.21	5,000	61,050	5,000	Mar 25 04:12 PM
Bancel Stephane	Chief Executive Officer	Mar 24	Sale	137.07	9,000	1,233,630	6,391,868	Mar 26 04:34 PM
Hoge Stephen	President	Mar 24	Sale	137.07	5,000	685,350	1,609,597	Mar 25 04:13 PM
Andres Juan	See remarks	Mar 24	Sale	137.07	5,000	685,350	0	Mar 25 04:12 PM
Hoge Stephen	President	Mar 23	Option Exercise	4.29	15,000	64,400	1,624,597	Mar 25 04:13 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 23	Option Exercise	20.93	6,600	138,138	7,501	Mar 25 04:11 PM
Hoge Stephen	President	Mar 23	Sale	142.08	15,000	2,131,268	1,609,597	Mar 25 04:13 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 23	Sale	145.55	6,600	960,630	901	Mar 25 04:11 PM
Zaks Tal Zvi	Chief Medical Officer	Mar 22	Option Exercise	20.93	1,199	25,095	1,199	Mar 23 04:19 PM
Andres Juan	See remarks	Mar 22	Option Exercise	12.21	5,000	61,050	5,000	Mar 23 04:15 PM
Zaks Tal Zvi	Chief Medical Officer	Mar 22	Sale	144.82	1,199	173,640	0	Mar 23 04:19 PM
Andres Juan	See remarks	Mar 22	Sale	144.19	5,000	720,950	0	Mar 23 04:15 PM
Bancel Stephane	Chief Executive Officer	Mar 19	Sale	142.64	11,046	1,575,547	110,476	Mar 23 04:07 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 18	Option Exercise	25.77	6,600	170,058	7,501	Mar 19 05:18 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 18	Sale	144.39	6,600	952,974	901	Mar 19 05:18 PM
Bancel Stephane	Chief Executive Officer	Mar 18	Sale	144.39	10,000	1,443,900	7,494,880	Mar 19 05:16 PM
Andres Juan	See remarks	Mar 17	Option Exercise	12.21	5,000	61,050	5,000	Mar 18 04:08 PM
Bancel Stephane	Chief Executive Officer	Mar 17	Sale	149.78	9,000	1,348,020	6,402,868	Mar 19 05:16 PM
Andres Juan	See remarks	Mar 17	Sale	149.78	5,000	748,900	0	Mar 18 04:08 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 16	Option Exercise	25.93	6,600	171,138	7,501	Mar 18 04:11 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 16	Sale	148.50	6,600	980,100	901	Mar 18 04:11 PM
Hoge Stephen	President	Mar 15	Option Exercise	4.29	15,000	64,400	1,624,597	Mar 16 04:05 PM
Zaks Tal Zvi	Chief Medical Officer	Mar 15	Option Exercise	20.91	10,034	209,783	10,034	Mar 16 04:07 PM
Andres Juan	See remarks	Mar 15	Option Exercise	12.21	5,000	61,050	5,000	Mar 16 04:03 PM
Andres Juan	See remarks	Mar 15	Sale	137.00	5,000	685,000	0	Mar 16 04:03 PM
Hoge Stephen	President	Mar 15	Sale	137.00	15,000	2,055,000	1,609,597	Mar 16 04:05 PM
Zaks Tal Zvi	Chief Medical Officer	Mar 15	Sale	140.68	10,034	1,411,535	0	Mar 16 04:07 PM
Hoge Stephen	President	Mar 12	Option Exercise	10.90	5,000	54,500	1,614,597	Mar 16 04:05 PM
Hoge Stephen	President	Mar 12	Sale	134.04	5,000	670,200	1,609,597	Mar 16 04:05 PM
Bancel Stephane	Chief Executive Officer	Mar 12	Sale	135.73	11,046	1,499,289	121,522	Mar 15 04:10 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 11	Option Exercise	25.93	6,600	171,138	7,501	Mar 12 05:53 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 11	Sale	133.29	6,600	879,714	901	Mar 12 05:53 PM
Bancel Stephane	Chief Executive Officer	Mar 11	Sale	133.29	10,000	1,332,900	7,504,880	Mar 12 05:55 PM
Andres Juan	See remarks	Mar 10	Option Exercise	12.21	5,000	61,050	5,000	Mar 11 04:54 PM
Bancel Stephane	Chief Executive Officer	Mar 10	Sale	133.24	9,000	1,199,160	6,413,868	Mar 12 05:55 PM
Andres Juan	See remarks	Mar 10	Sale	133.24	5,000	666,200	0	Mar 11 04:54 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 09	Option Exercise	25.93	6,600	171,138	7,501	Mar 10 04:03 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 09	Sale	127.11	6,600	838,926	901	Mar 10 04:03 PM
Zaks Tal Zvi	Chief Medical Officer	Mar 08	Option Exercise	18.11	16,478	298,446	16,478	Mar 10 04:01 PM
Andres Juan	See remarks	Mar 08	Option Exercise	12.21	5,000	61,050	5,000	Mar 10 04:02 PM
Andres Juan	See remarks	Mar 08	Sale	129.41	5,000	647,050	0	Mar 10 04:02 PM
Zaks Tal Zvi	Chief Medical Officer	Mar 08	Sale	128.59	16,478	2,118,863	0	Mar 10 04:01 PM
Bancel Stephane	Chief Executive Officer	Mar 05	Sale	128.18	11,046	1,415,858	132,568	Mar 08 05:12 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 04	Option Exercise	25.93	6,600	171,138	7,501	Mar 05 04:28 PM
Bancel Stephane	Chief Executive Officer	Mar 04	Sale	128.58	10,000	1,285,800	7,514,880	Mar 05 04:15 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 04	Sale	128.58	6,600	848,628	901	Mar 05 04:28 PM
Andres Juan	See remarks	Mar 03	Option Exercise	12.21	5,000	61,050	5,000	Mar 04 04:15 PM
Hoge Stephen	President	Mar 03	Option Exercise	0.99	10,000	9,900	1,619,597	Mar 04 04:18 PM
Bancel Stephane	Chief Executive Officer	Mar 03	Sale	145.60	9,000	1,310,400	6,424,868	Mar 05 04:15 PM
Andres Juan	See remarks	Mar 03	Sale	145.60	5,000	728,000	0	Mar 04 04:15 PM
Hoge Stephen	President	Mar 03	Sale	145.60	10,000	1,456,000	1,609,597	Mar 04 04:18 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 02	Option Exercise	25.93	6,600	171,138	7,501	Mar 04 04:13 PM
Hoge Stephen	President	Mar 02	Option Exercise	0.99	10,000	9,900	1,619,597	Mar 04 04:18 PM
HENDERSON LORI M.	General Counsel and Secretary	Mar 02	Sale	153.77	6,600	1,014,882	901	Mar 04 04:13 PM
Hoge Stephen	President	Mar 02	Sale	153.77	10,000	1,537,700	1,609,597	Mar 04 04:18 PM
Andres Juan	See remarks	Mar 01	Option Exercise	12.21	5,000	61,050	5,000	Mar 02 04:08 PM
Zaks Tal Zvi	Chief Medical Officer	Mar 01	Option Exercise	13.21	10,000	132,150	10,000	Mar 02 04:15 PM
Andres Juan	See remarks	Mar 01	Sale	153.84	5,000	769,200	0	Mar 02 04:08 PM
Zaks Tal Zvi	Chief Medical Officer	Mar 01	Sale	150.45	10,000	1,504,518	0	Mar 02 04:15 PM
Bancel Stephane	Chief Executive Officer	Feb 26	Sale	154.70	11,046	1,708,845	143,614	Mar 01 04:11 PM
Bancel Stephane	Chief Executive Officer	Feb 25	Sale	150.89	10,000	1,508,900	7,524,880	Feb 26 04:49 PM
AFEYAN NOUBAR	Director	Feb 24	Sale	146.19	1,753,697	256,378,924	12,869,462	Feb 24 08:31 PM
Bancel Stephane	Chief Executive Officer	Feb 24	Sale	150.41	9,000	1,353,690	6,434,868	Feb 26 04:49 PM
Hoge Stephen	President	Feb 24	Sale	150.41	5,000	752,050	1,609,597	Feb 25 05:54 PM
Hoge Stephen	President	Feb 23	Option Exercise	0.99	10,000	9,900	1,629,597	Feb 25 05:54 PM
AFEYAN NOUBAR	Director	Feb 23	Sale	145.35	2,947,638	428,433,185	14,623,159	Feb 24 08:30 PM
Hoge Stephen	President	Feb 23	Sale	147.08	15,000	2,206,273	1,614,597	Feb 25 05:54 PM
Zaks Tal Zvi	Chief Medical Officer	Feb 22	Option Exercise	12.21	5,000	61,050	5,000	Feb 24 04:08 PM
Andres Juan	See remarks	Feb 22	Option Exercise	12.21	5,000	61,050	5,000	Feb 24 04:16 PM
Andres Juan	See remarks	Feb 22	Sale	166.63	5,000	833,150	0	Feb 24 04:16 PM
Zaks Tal Zvi	Chief Medical Officer	Feb 22	Sale	164.84	5,000	824,196	0	Feb 24 04:08 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience